Ketamine in Hip Arthroplasty: Clinical Review Insights

Systematic Review of Ketamine in Hip Surgery

A recent systematic review published on June 1, 2026, in PubMed evaluates the efficacy and safety of ketamine in total hip arthroplasty. The review provides a comprehensive analysis of ketamine's potential use as an anesthetic or analgesic in surgical settings, specifically focusing on hip replacement procedures. This analysis is crucial for understanding ketamine's role in pain management and its implications for clinical practices.

Mechanism and Context of Ketamine Use

Ketamine, traditionally known as an anesthetic, has gained interest for its analgesic properties and rapid-acting antidepressant effects. In the context of total hip arthroplasty, ketamine is considered for its potential to reduce postoperative pain and opioid consumption. The review highlights ketamine's pharmacological action, which involves NMDA receptor antagonism, potentially leading to effective pain relief and improved patient outcomes.

Implications for Clinical Guidelines and Research

The findings from this review could influence clinical guidelines by providing evidence-based insights into ketamine's use in surgical settings. While current guidelines may not fully incorporate ketamine for hip arthroplasty, this review paves the way for further investigation and potential inclusion in pain management protocols. Additionally, the review underscores the need for more extensive clinical trials to explore ketamine's broader applications in pain management beyond surgical contexts.

Risks and Unknowns

Despite promising findings, the review also points out several risks and unknowns associated with ketamine use. Potential side effects, such as dissociation and cardiovascular issues, warrant careful consideration. The review calls for more rigorous studies to establish optimal dosing, administration methods, and long-term safety profiles. Without addressing these concerns, ketamine's integration into clinical practice remains cautious.

Looking Forward: Future Research and Policy

While the review provides valuable insights, its impact on policy or market dynamics is limited without further regulatory developments or large-scale clinical trials. Future research should focus on addressing the identified risks and expanding the evidence base for ketamine's use in various medical contexts. Policymakers and researchers must collaborate to ensure that ketamine's potential benefits are realized safely and effectively.